Amino Acid Supplement May Help Your Immune System Fight Cancer and Viruses, According to Research in Animals
A single amino acid is the most depleted amino acid across three distinct diseases: colon cancer, influenza, and SARS-CoV-2, and researchers say that’s unlikely to be a coincidence. The finding emerged from a July 2026 study at Rockefeller University, and it points to something that wasn’t fully understood before: the connection between this amino acid and the immune system may be far more direct than previously thought.
The study’s central discovery concerns a protein most people have never heard of. When this amino acid runs low, cells lose the ability to produce a surface protein that acts as a flag for the immune system. Without that flag, the immune system cannot identify which cells are dangerous. Cancer cells and virus-infected cells can essentially disappear from immune view. The researchers found that a moderate dose of the amino acid, roughly equivalent to the amount in a couple of over-the-counter tablets, could potentially restore that signal, at least in mice.
All of the disease-model experiments behind these findings were conducted in animals. The results are striking, but whether they translate to measurable clinical benefit in people remains to be established through human trials.
The Arginine – Immune System Connection
The amino acid is arginine. Sohail Tavazoie, who leads Rockefeller University’s Elizabeth and Vincent Meyer Laboratory of Systems Cancer Biology, has spent years studying the link between arginine and disease. In 2023, his team found that depriving colon cancer cells of arginine caused them to accumulate more mutations. The 2026 research takes things further.
Their latest work shows that arginine deficiency may also weaken the immune system directly in animals. When arginine is scarce, cells struggle to produce MHC-1, a protein that helps alert the immune system to threats such as mutated cells and invading viruses.
MHC-1 proteins sit on the surface of cells throughout the body, displaying foreign or abnormal proteins to T cells, which then rally other immune cells to respond. In an arginine-scarce environment, ribosomes, the molecular machines that assemble proteins, stall when attempting to translate MHC-1, unable to complete the protein because arginine is unavailable. That leads to far fewer warning signals on cell surfaces, allowing cancer cells and viral proteins to evade detection more easily.
How much arginine a cell has determines whether the immune system can read the danger signals displayed on that cell’s surface. The July 2026 paper published in Cell established the specific molecular step where this breakdown occurs.
Why Arginine Is So Central to This Process
MHC-1 is assembled from many arginine-containing segments, making it one of the proteins most vulnerable to arginine shortages. The 2026 Cell study pinpointed where the production line breaks down: at the ribosome, the cellular machine that reads genetic instructions and builds proteins step by step.
Arginine is encoded by six different sets of genetic instructions (called codons – three-letter sequences in DNA that each specify one amino acid). Most amino acids rely on far fewer. Because MHC-1 requires so many arginine-coded steps, any shortage of the amino acid creates a bottleneck specifically for that protein. Other proteins less dependent on arginine are less affected.
In 2023, Tavazoie’s team, with first author Dennis Hsu, published a paper in Science Advances reporting that arginine deprivation causes colon cancer cells to accumulate mutations specifically at arginine codons. The 2026 findings add another layer: low arginine not only makes cancer cells more genetically unstable, it also makes them harder for the immune system to detect.
What the Mouse Studies Found
These results come entirely from animal experiments.
In mice, diets rich in arginine led to fewer colon tumors and milder viral infections, while low-arginine diets worsened outcomes for flu, COVID-19, and tumor growth. The same directional pattern held across three separate disease models – a consistent signal, even if the research remains in animal stages.
Increasing arginine in the diets of mice restored MHC-1 production, reduced colon tumor growth, and improved their response to influenza and SARS-CoV-2. The mechanism appears to be the same in each case: more arginine means ribosomes can complete MHC-1 assembly, cells display proper immune signals, and T cells can do their job.
The research also shows that the mechanism is dynamic. Even after infection has begun, restoring arginine can partially rescue MHC-1 expression in animal models, suggesting – in mice – that restoring arginine levels mid-infection could still be useful, not only as a preventive measure.
A Moderate Dose May Be Enough
Researchers found that a moderate dose of arginine – about as much as found in a couple of over-the-counter tablets – could potentially rescue expression of the genes responsible for MHC-1 production. Arginine supplements are already widely sold for cardiovascular and sports recovery purposes, and the quantities relevant to this animal study are commercially available.
The researchers themselves are cautious about overstating the findings. Tavazoie has said it’s far too early to claim arginine supplements could prevent or treat these diseases in people, adding that he doesn’t want the takeaway to be that everyone should be consuming arginine all the time. His team is interested in following up with clinical studies of arginine supplementation in people.
Low arginine causes ribosomes to stall during MHC-1 protein assembly, stripping cancer cells of the immune flags T cells use to detect tumors. Checkpoint inhibitors – drugs that free T cells to attack cancer – have transformed treatment for many cancers, but most patients still don’t respond to them. Checkpoint inhibitors rely on T cells being able to recognize cancer cell surfaces. If those surfaces aren’t displaying MHC-1 flags, T cells have nothing to home in on. Arginine’s role in that display mechanism could help explain why some patients don’t respond to immunotherapy.
Where You Get Arginine Naturally
L-arginine is an amino acid that helps the body build protein. The body usually makes all the L-arginine it needs, and it’s found in most protein-rich foods, including fish, red meat, poultry, soy, whole grains, beans, and dairy products. For most healthy adults eating a varied diet, deficiency isn’t the norm.
Arginine is classified as a semi-essential amino acid, meaning the body both produces it and absorbs it from food. Some adults don’t produce sufficient amounts, and if they don’t absorb enough from their diet, they can develop a deficiency. Illness is one pathway to depletion, since arginine levels are already known to be low in cancers, and viruses reduce arginine levels in the tissues they infect.
The foods with the highest arginine concentrations include turkey breast, pumpkin seeds, soybeans, peanuts, and legumes like lentils and chickpeas. For people who eat a protein-adequate diet with variety, getting enough arginine through food alone is realistic. Supplements are generally considered appropriate only when a healthcare provider identifies a specific need. L-arginine can cause interactions in people with certain health conditions, and should not be taken after a recent heart attack, or without provider approval by adults over 65 or those who are pregnant or breastfeeding. Anyone taking blood pressure medications or blood thinners should discuss arginine supplements with a doctor before starting, as the Mayo Clinic notes these are among the most common interaction categories.
If you’re thinking more broadly about diet and cancer risk, foods that raise or reduce colon cancer risk covers the wider dietary picture around one of the most common cancers in the U.S.
What to Do With This Research Now
The Rockefeller findings don’t offer a supplement protocol for the general public. The researchers are explicit: clinical trials in humans haven’t happened yet. In mice, eating a high-arginine diet reduced colon tumors and offered protection against influenza and COVID-19, Tavazoie and colleagues reported in Cell in July 2026. Whether those results translate to human treatment still needs to be established through properly designed trials.
The study does establish a clear molecular explanation for something previously observed but poorly understood: low-arginine states associated with cancer and serious viral illness may also impair the immune system’s ability to fight back. In animal models, the two problems share a common driver.
For practical purposes, maintaining adequate protein intake through whole foods is a reasonable starting point. If you’re over 60, recovering from a serious illness, or being treated for cancer, a conversation with your doctor about amino acid status – including arginine – is worth having in light of this research. The dose that restored MHC-1 gene expression in mice was modest, equivalent to a couple of over-the-counter tablets. Whether that translates to a measurable clinical benefit in people is the question the Tavazoie lab is now working to answer, and the answer will require human trial data – not animal studies alone.
Disclaimer: The author is not a licensed medical professional. The information provided is for general informational and educational purposes only and is based on research from publicly available, reputable sources. It is not intended to constitute, and should not be relied upon as, medical advice, diagnosis, or treatment. Always consult a licensed physician or other qualified healthcare provider regarding any medical condition, symptoms, or medications. Do not disregard, avoid, or delay seeking professional medical advice or treatment because of information contained herein.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.
